Frequently asked questions
In 2022, the global Enzymatic DNA Synthesis Market is expected to be worth USD 251.5 million.
The Enzymatic DNA Synthesis Market is estimated to increase at a CAGR of 46.30% between 2023 and 2030, reaching USD 5278.2 Million in 2030.
The Biotechnology and Pharmaceutical Companies category dominates the global market
Drug discovery and development maintained the greatest market share of roughly 45.27% in 2022
The Services section is another quickly growing component in the Enzymatic DNA Synthesis Market.
North America will account for more than half of the market in 2022
The top players include Telesis Bio Inc, Evonetix, Ansa Biotechnologies, Inc., Camena Bio, GenScript Biotech Corp., Molecular Assemblie, DNA Script, Touchlight, Synbio Technologies and Twist Bioscience.
Increasing demand for synthetic DNA in research, diagnostics, and therapeutics; advancements in enzymatic DNA synthesis technologies, enabling faster and more accurate synthesis; and increased investments in genomics research and personalized medicine, driving the need for efficient DNA synthesis methods.
High upfront costs associated with enzymatic DNA synthesis technologies, Challenges in scaling up enzymatic DNA synthesis for large-scale production and Stringent regulatory requirements for the use of synthetic DNA in certain applications are the key restraints in the market
Development of novel enzymes and technologies for more efficient and cost-effective DNA synthesis, Expansion of applications in fields such as synthetic biology, gene editing, and DNA-based data storage and Collaboration and partnerships between industry players to accelerate research and commercialization efforts are the opportunities in the market.